The Evolution of Topical Formulations in Psoriasis

Area of Science:

• Dermatology
• Pharmaceutics

Background:

• Topical therapies are standard for mild-to-moderate psoriasis.
• Daily application of topical treatments poses a significant burden, leading to poor patient adherence.
• There is a need for more effective and acceptable topical treatments.

Purpose of the Study:

• To evaluate a novel calcipotriol/betamethasone diproprionate aerosol foam formulation for psoriasis.
• To assess the efficacy, patient acceptability, and adherence of the foam vehicle compared to traditional formulations.

Main Methods:

• A novel aerosol foam vehicle was developed for topical psoriasis treatment.
• The foam formulation contains calcipotriol and betamethasone diproprionate.
• Comparative efficacy and patient satisfaction studies were conducted.

Main Results:

• The calcipotriol/betamethasone diproprionate aerosol foam demonstrated rapid and superior efficacy compared to ointment and gel formulations.
• The foam vehicle was easily spread, non-greasy, and well-accepted by patients.
• Improved patient satisfaction and treatment adherence were observed with the foam formulation.

Conclusions:

• The novel aerosol foam formulation addresses unmet clinical needs in mild-to-moderate psoriasis management.
• This optimized foam formulation has the potential to enhance treatment adherence and patient outcomes.